Logical Assessment

Long/short equity, biotech, healthcare, small-cap
Logical Assessment
Long/short equity, biotech, healthcare, small-cap
Contributor since: 2012
While Amarin Continues To Go Rancid, Neptune Will Soar
GlassesOff: The Most Disruptive Technology In Mobile
Organovo May Be Big Pharma's Salvation
As The Patent Cliff Approaches, Buy TrovaGene
ARM Holdings' Biotech Twin: FluoroPharma
Is Sunshine The Solution To Device Tax Blues?